Max Planck Innovation announces new venture capital fund

Thursday 14 May 2009

Max Planck Innovation GmbH, the technology transfer arm of the Max Planck Society, has announced the launch of a new €100 million fund to invest in pharmaceutical projects originating from the society’s research organisations.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany